Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 18, Issue 8, 1999, Pages 535-538

  Agalar, C ^a   Usubutun, S ^a   Turkyilmaz, R ^a  

^a Social Secty Ins Training Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DOXYCYCLINE; RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRUCELLOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIBIOTICS, ANTITUBERCULAR; BRUCELLOSIS; CHI-SQUARE DISTRIBUTION; CIPROFLOXACIN; DOXYCYCLINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RIFAMPIN; TREATMENT OUTCOME;

EID: 0032757199     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050344     Document Type: Article

References (19)

1. 1. Hall WH: Modern chemotherapy for brucellosis in humans. Reviews of Infectious Diseases (1990) 12:1060-1099
2. 2. Young JE: Brucella species In: Mandell GL, Dolin R, Bennett JE (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp 2053-2057
3. 3. Food and Agricultural Organization: World Health Organization Expert Committee on Brucellosis. 6th report. WHO Technical Report Series (1986) 740:56-57
4. 4. Ariza J, Gudiol F, Pallares R, Fernandez-Viladrich P, Rufi G, Corredoira J, Miravitiles MR: Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. Annals of Internal Medicine (1992) 117:25-30
5. 5. Ruíz-Castenade E: Laboratory diagnosis of brucellosis in man. Bulletin of the World Health Organization (1961) 24:73-84
6. 6. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-44, NCCLS, Villanova, PA (1990)
7. 7. Bosch J, Linares J, Lopez de Goicoechea MJ, Ariza J, Cisnal MC, Martin R: In-vitro activity of ciprofloxacin, ceftriaxone and five other antimicrobial agents against 95 strains of Brucella melitensis. Journal of Antimicrobial Chemotherapy (1986) 17:459-461
8. 8. Garcia Rodriguez JA, Garcia Sanchez JE, Trujillano I, Garcia Sanchez E, Garcia Garcia MI, Fresnadillo MJ: Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones. Antimicrobial Agents and Chemotherapy (1995) 39:1194-1195
9. 9. Baykal M, Akalin HE, Firat M, Serin A: In vitro activity and clinical efficacy of ofloxacin infections due to Brucella melitensis. Reviews of Infectious Diseases (1989) 11, Supplement 5:993-994
10. 10. Garcia-Rodriguez JA, Garcia-Sanchez JE, Trujillano I, Munoz Bbellido JL: In vitro activity of new quinolones against Brucella melitensis. Reviews of Infectious Diseases (1989) 11, Supplement 5:992-993
11. 11. Khan MY, Dizon M, Kiel FW: Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin and other selected antimicrobial agents against Brucella melitensis. Antimicrobial Agents and Chemotherapy (1989) 33:1409-1410
12. 12. Qadri SM, Akhtar M, Ueno Y, al-Sibai MB: Susceptibility of Brucella melitensis to flouroquinolones. Drugs under Experimental and Clinical Research (1989) 15:483-485
13. 13. Doǧanay M, Aygen B: Use of ciprofloxacin in the treatment of brucellosis. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:74-75
14. 14. al-Sibai MB, Halim MA, el-Shaker MM, Khan BA, Qadri SM: Efficacy of ciprofloxacin for treatment of Brucella melitensis infections. Antimicrobial Agents and Chemotherapy (1992) 36:150-152
15. 15. Lang R, Raz R, Sacks T, Shapiro M: Failure of prolonged treatment with ciprofloxacin in acute brucellosis. Journal of Antimicrobial Chemotherapy (1990) 26:841-846
16. 16. Lang R, Rubinstein E: Quinolones for the treatment of brucellosis. Journal of Antimicrobial Chemotherapy (1992) 29:357-363
17. 17. Rubinstein E: Management of brucellosis. In: Pechére JC (ed): Intracellular bacterial infections. Cambridge Medical Publication, Cambridge (1996) pp 93-98
18. 18. Acocella G, Bertrand A, Beytour J, Durrande JB, Rodriguez JA, Kosmidis J, Micoud M, Rey M, Zapata MR, Roux J, Stahl JP: Comparison of three different regimens in the treatment of acute brucellosis: a multicenter multinational study. Journal of Antimicrobial Chemotherapy (1989) 23:433-439
19. 19. Akova M, Ömrüm U, Akalin E, Hayran M, Ünal S, Gür D: Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin. Antimicrobial Agents and Chemotherapy (1993) 37:1831-1834